NeuroscienceParkinsonism & Related DisordersPeer-reviewed
Dopamine replacement remediates risk aversion in Parkinson’s disease in a value-independent manner
Mariya V. Cherkasova, Jeffrey C. Corrow, Alisdair Taylor…·Jason J.S. Barton
This study shows that dopamine replacement in Parkinson’s disease patients reduces risk aversion in a value-independent manner, while also increasing sensitivity to expected values.
4 citations